Organon Past Earnings Performance

Past criteria checks 4/6

Organon's earnings have been declining at an average annual rate of -29.7%, while the Pharmaceuticals industry saw earnings growing at 13.1% annually. Revenues have been declining at an average rate of 2.4% per year. Organon's return on equity is 263.9%, and it has net margins of 20.3%.

Key information

-29.7%

Earnings growth rate

-30.0%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate-2.4%
Return on equity263.9%
Net Margin20.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Organon makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:7XP Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246,4091,3011,757473
30 Jun 246,3461,0001,873499
31 Mar 246,3471,0471,887511
31 Dec 236,2631,0231,891528
30 Sep 236,1505851,892536
30 Jun 236,1687541,794526
31 Mar 236,1457461,766504
31 Dec 226,1749171,702471
30 Sep 226,2921,0111,717439
30 Jun 226,3551,1071,665398
31 Mar 226,3651,3041,658368
31 Dec 216,3041,3511,669339
30 Sep 216,3141,5251,620289
30 Jun 216,3271,7621,553257
31 Mar 216,2581,9171,421232
31 Dec 206,5322,2561,356210
31 Dec 197,7773,3061,443220
31 Dec 189,7772,1531,956365
31 Dec 1710,5001,8012,250355

Quality Earnings: 7XP has high quality earnings.

Growing Profit Margin: 7XP's current net profit margins (20.3%) are higher than last year (9.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 7XP's earnings have declined by 29.7% per year over the past 5 years.

Accelerating Growth: 7XP's earnings growth over the past year (122.4%) exceeds its 5-year average (-29.7% per year).

Earnings vs Industry: 7XP earnings growth over the past year (122.4%) exceeded the Pharmaceuticals industry 28.7%.


Return on Equity

High ROE: Whilst 7XP's Return on Equity (263.89%) is outstanding, this metric is skewed due to their high level of debt.


Return on Assets


Return on Capital Employed


Discover strong past performing companies